Cargando…

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families

It is estimated that about 5–10% of breast cancer cases may be due to inherited predisposition. Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2. The first linkage and mutational studies suggested that mutations in these two genes would account for the majority of high-...

Descripción completa

Detalles Bibliográficos
Autores principales: Osorio, A, Barroso, A, Martínez, B, Cebrián, A, Román, J M San, Lobo, F, Robledo, M, Benítez, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374482/
https://www.ncbi.nlm.nih.gov/pubmed/10755399
http://dx.doi.org/10.1054/bjoc.1999.1089
_version_ 1782154464124207104
author Osorio, A
Barroso, A
Martínez, B
Cebrián, A
Román, J M San
Lobo, F
Robledo, M
Benítez, J
author_facet Osorio, A
Barroso, A
Martínez, B
Cebrián, A
Román, J M San
Lobo, F
Robledo, M
Benítez, J
author_sort Osorio, A
collection PubMed
description It is estimated that about 5–10% of breast cancer cases may be due to inherited predisposition. Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2. The first linkage and mutational studies suggested that mutations in these two genes would account for the majority of high-risk breast cancer families, but recent studies show how the proportion of families due to BRCA1 or BRCA2 mutations strongly depends on the population and the types of family analyzed. It is now clear that, in the context of families with a modest cancer profile, which are the most commonly found in the clinical practice, the percentage of mutations found is much lower than that suggested by the first studies. In the present study, we analyze a group of 32 Spanish families, which contatined at least three cases of female breast cancer (at least one of them diagnosed before the age of 50 years), for the presence of mutations in the BRCA genes. The total proportion of mutations was low (25%), although the percentage of mutations in the BRCA1 and BRCA2 genes was higher, considering the breast and ovarian cancer families and the male breast cancer families respectively. Our results are in agreement with the idea that a great proportion of moderate-risk cancer families could be due to low penetrance susceptibility genes distinct from BRCA1 or BRCA2. © 2000 Cancer Research Campaign
format Text
id pubmed-2374482
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23744822009-09-10 Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families Osorio, A Barroso, A Martínez, B Cebrián, A Román, J M San Lobo, F Robledo, M Benítez, J Br J Cancer Regular Article It is estimated that about 5–10% of breast cancer cases may be due to inherited predisposition. Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2. The first linkage and mutational studies suggested that mutations in these two genes would account for the majority of high-risk breast cancer families, but recent studies show how the proportion of families due to BRCA1 or BRCA2 mutations strongly depends on the population and the types of family analyzed. It is now clear that, in the context of families with a modest cancer profile, which are the most commonly found in the clinical practice, the percentage of mutations found is much lower than that suggested by the first studies. In the present study, we analyze a group of 32 Spanish families, which contatined at least three cases of female breast cancer (at least one of them diagnosed before the age of 50 years), for the presence of mutations in the BRCA genes. The total proportion of mutations was low (25%), although the percentage of mutations in the BRCA1 and BRCA2 genes was higher, considering the breast and ovarian cancer families and the male breast cancer families respectively. Our results are in agreement with the idea that a great proportion of moderate-risk cancer families could be due to low penetrance susceptibility genes distinct from BRCA1 or BRCA2. © 2000 Cancer Research Campaign Nature Publishing Group 2000-04 2000-03-06 /pmc/articles/PMC2374482/ /pubmed/10755399 http://dx.doi.org/10.1054/bjoc.1999.1089 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Osorio, A
Barroso, A
Martínez, B
Cebrián, A
Román, J M San
Lobo, F
Robledo, M
Benítez, J
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
title Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
title_full Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
title_fullStr Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
title_full_unstemmed Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
title_short Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
title_sort molecular analysis of the brca1 and brca2 genes in 32 breast and/or ovarian cancer spanish families
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374482/
https://www.ncbi.nlm.nih.gov/pubmed/10755399
http://dx.doi.org/10.1054/bjoc.1999.1089
work_keys_str_mv AT osorioa molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT barrosoa molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT martinezb molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT cebriana molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT romanjmsan molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT lobof molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT robledom molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies
AT benitezj molecularanalysisofthebrca1andbrca2genesin32breastandorovariancancerspanishfamilies